Families expect cognitive decline as a normal part of getting older. We watch relatives lose their memories and accept the loss. Past medical trials regarding Alzheimer's disease failed 99 percent of the time, early signs of brain changes were missed, and precious years for early screening and treatment were lost.But new science changes this reality. Doctors now use blood tests and brain imaging for accurate diagnosis. They prescribe immunotherapy treatments that clear toxic brain plaques and slow cognitive decline by 30 percent. Dr. Marc Agronin shares his exact methods for geriatric psychiatry and dementia care. Learn how early medical intervention stops memory loss as he reveals his new research.🎯 PRIMARY DISCOVERY[19:51]:"Someone goes from thinking, ‘I have a terminal disease,’ to ‘I have a manageable disease and I am going to continue to live and do things.’ Their whole mindset changes."Dr. Agronin reveals the exact medical advancements that give patients their lives back.🩺 PRACTICE UPGRADE [30:56]:"We have all sorts of vital signs we check by routine. We need to have a cognitive vital sign that we check, and something like a Mini-Mental, Montreal Cognitive Assessment, something like that is practical to be done in primary care."Discover how doctors catch memory loss early with simple annual tests.✨ MEDICAL MILESTONE [46:29]:"We see over the 18 months of the studies that the rate of decline in terms of both cognition and function is on average about 30 percent slower. And then we know that after 18 months, it is a very slow rate of reaccumulation."Hear how new monoclonal antibodies melt away brain plaques and stop memory loss.CHAPTERS:00:00 - Meet Alzheimer’s Research Leader Dr. Marc Agronin01:45 - Why a Career in Geriatric Psychiatry and Dementia Care?06:17 - Why Alzheimer’s Research Is Entering a Breakthrough Era08:07 - Why Alzheimer’s Disease Is Rising Worldwide11:04 - How to Explain Alzheimer’s Diagnosis to Patients and Families16:11 - The Biggest Scientific Breakthroughs in Alzheimer’s Disease24:30 - How New Biomarker Guidelines Are Changing Alzheimer’s Diagnosis29:57 - Why Early Screening for Cognitive Decline Matters36:13 - Brain Health Habits That May Reduce Alzheimer’s Risk42:50 - Current Alzheimer’s Medications and How They Help Cognition45:45 - New Anti-Amyloid Treatments That Slow Alzheimer’s Progression50:01 - Understanding ARIA Side Effects in Alzheimer’s Immunotherapy54:09 - Emerging Alzheimer’s Treatments and Future Research Directions01:02:09 - The Role of Empathy and Person-Centered Dementia CareLinks:Full transcript and show notes: https://www.psychiatrist.com/jcp/ep11-what-clinicians-should-know-about-alzheimers-treatment-marc-agronin/ Journal of Clinical Psychiatry: psychiatrist.com/jcp/Dr. Marc Agronin: https://www.marcagronin.com/Figure referenced at 53:35 comes from Figure 1 in the paper “Alzheimer’s Disease Drug Development Pipeline: 2025.”: https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/trc2.70098#AlzheimersResearch #BrainHealth #GeriatricPsychiatry

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related